Zyus Life Sciences Corporation (TSE:ZYUS) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
ZYUS Life Sciences Corporation, a company specializing in cannabinoid-based pharmaceuticals for pain management, has announced its participation in the Sidoti May Virtual Investor Conference on May 8-9, 2024. Brent Zettl, President and CEO, will present at the event and engage in one-on-one meetings with investors. The conference provides a platform for ZYUS to showcase its innovations and growth prospects to potential investors.
For further insights into TSE:ZYUS stock, check out TipRanks’ Stock Analysis page.
